Check-Cap ’ s cancer screening capsule will have U.S. study
Check-Cap (NSDQ:CHEK) said its X-ray-enabled, colorectal cancer-screening capsule will have a pilot study in the United States.
The Isfiya, Israel-based startup makes the C-Scan System, an ingestible capsule used to detect precancerous polyps without the need for laxatives or an invasive procedure. The C-Scan system uses an ultra-low dose X-ray capsule, an integrated positioning, control, and recording system, and proprietary software to generate a 3D map of the inner lining of the colon. It received approval from Israel’s Ministry of Health Medical Device division (AMAR) and the CE Mark in 2018.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Check-Cap’s cancer screening capsule will have U.S. study appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Implants News Well Oncology Research & Development Check-Cap FDA New York University Source Type: news
More News: Blogging | Cancer | Cancer & Oncology | Clinical Trials | Colon Cancer | Colorectal Cancer | Gastrointestinal Polyps | Israel Health | Medical Devices | Middle East Health | New York University | PET Scan | Polyps | Study | USA Health